Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

80.08 USD -0.27 (-0.34%)
Official Closing Price Updated: 5:47 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Arena Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9 Next >
Stocks Showing Improved Relative Strength: Arena Pharmaceuticals
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. Will it continue? 
From Investor's Business Daily
Noteworthy Thursday Option Activity: ARNA, JPM, STAA
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arena Pharmaceuticals Inc (ARNA), where a total volume of 2,195 contracts has been... 
Tags Stocks
From Market News Video
Medical Stocks Blistered On Sanders Proposal — Is This A Correction?
Medical stocks continued a two-day plunge Thursday on worries over a proposal from Bernie Sanders, a senator and presidential candidate, for a single-payer health care system in the U.S. 
From Investor's Business Daily
Arena Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
Analysts Forecast 13% Gains Ahead For The Holdings of FYX
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Arena Pharmaceuticals Inc (ARNA) Q4 2018 Earnings Conference Call Transcript
ARNA earnings call for the period ending December 31, 2018. 
Tags ARNA Market News
From Motley Fool
The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags PEN JAZZ ANCN
From Benzinga
Implied JKK Analyst Target Price: $224
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week peaks ... 
Tags XBI Biotech AMGN
From Benzinga
Analysts Forecast 25% Gains Ahead For The Holdings of FYX
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
65 Biggest Movers From Yesterday
Gainers Axsome Therapeutics, Inc. (NASDAQ: AXSM) surged 161.22 percent to close at $6.87 on Friday after the company disclosed ... 
Tags MOGU News Pre/Market Outlook
From Benzinga
Arena Pharmaceuticals Earns Relative Strength Rating Upgrade
Arena Pharmaceuticals sees its Relative Strength Rating move into the elite 90-plus level. 
From Investor's Business Daily
42 Stocks Moving In Monday's Mid-Day Session
Gainers Axsome Therapeutics, Inc. (NASDAQ: AXSM) jumped 215 percent to $8.28 after the company disclosed that it has achieved its ... 
Tags ROKU Health Care NVTA
From Benzinga
Interesting ARNA Put And Call Options For February 8th
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading this week, for the February 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Trying To Close In On Key Technical Measure
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. Will it continue? 
From Investor's Business Daily
Arena Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS Rating
Arena Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
Analysts Anticipate 20% Upside For FYC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
January 2019 Options Now Available For Arena Pharmaceuticals (ARNA)
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options begin trading today, for the January 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARNA... 
Tags Stocks
From Market News Video
Arena Pharmaceuticals Shows Market Leadership With Jump To 91 RS Rating
A Relative Strength Rating upgrade for Arena Pharmaceuticals shows improving technical performance. 
From Investor's Business Daily
My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy
These biotech upstarts have deep pockets and late-stage pipelines that could make them savvy buys. 
Tags REGN UTHR BLUE
From Motley Fool
ARNA February 2019 Options Begin Trading
Investors in Arena Pharmaceuticals Inc (ARNA) saw new options become available today, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure
For investors who are seeking exposure to the cannabis industry but consider pure-play companies too risky, there are many other ... 
Tags NTEC Health Care PMD
From Benzinga
64 Biggest Movers From Yesterday
Gainers uniQure N.V. (NASDAQ: QURE) shares jumped 35.66 percent to close at $30.93 on Thursday after the company reported all ... 
Tags ADMP DCPH GLBS
From Benzinga
Cramer's lightning round: This biotech has the perfect stock for this environment
Jim Cramer rattles off his take on callers' favorite stocks, including a biotechnology play ripe for the picking. 
Tags Fiat Chrysler Automobiles NV Investing/Stock Market Investing
From CNBC.com News
Why Arena Pharmaceuticals, Smart & Final Stores, and Tilray Jumped Today
Smart strategic moves helped these stocks gain ground. 
Tags ARNA UTHR Market News
From Motley Fool
Noteworthy Thursday Option Activity: RESI, CRMT, ARNA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Front Yard Residential Corp (RESI), where a total of 6,915 contracts have traded so far,... 
Tags Stocks
From Market News Video
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 48.6 percent to $1.58. uniQure N.V. (NASDAQ: QURE) shares ... 
Tags EZPW CGA APVO
From Benzinga
This Biotech Stock Is Flying On A $1.2 Billion Licensing Deal
Arena Pharmaceuticals rocketed in bullish fashion Thursday after announcing a $1.2 billion licensing deal with United Therapeutics for an arterial disease treatment. 
From Investor's Business Daily
Mid-Day Market Update: Smart & Final Stores Rises Following Strong Q3 Earnings; Remark Holdings Shares Drop
Midway through trading Thursday, the Dow traded down 0.44 percent to 24,969.12 while the NASDAQ climbed 0.25 percent to 7,154.28. The ... 
Tags CDTI Markets Intraday Update
From Benzinga
Here's Why Arena Pharmaceuticals Jumped as Much as 30.6% Today
The company moved to immediately monetize a promising drug candidate. For a cool $800 million up-front payment, investors can't complain. 
Tags Market News UTHR ARNA
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback